Wendy Yan

Senior Vice President, Global Head of Regulatory Affairs at BeiGene Ltd.

Wendy Yan

Wendy Yan

Senior Vice President, Global Head of Regulatory Affairs at BeiGene Ltd.

Overview
RelSci Relationships

1388

Number of Boards

1

Birthday

1966

Age

55
Relationships
View Relationship Details
RelSci Relationships are individuals Wendy Yan likely has professional access to. A relationship does not necessarily indicate a personal connection.
John V. Oyler

Co-Founder at BeiGene Ltd.

Relationship likelihood: Strong

Xiaodong Wang

Co-Founder at BeiGene Ltd.

Relationship likelihood: Strong

Lai Wang

Senior Vice President & Head of Global Research, Clinical Operation & Biometrics & Asia Pacific Clinical Development at BeiGene Ltd.

Relationship likelihood: Strong

Howard Liang

Chief Financial Officer & Chief Strategy Officer at BeiGene Ltd.

Relationship likelihood: Strong

Steven Young

Acting Head of Medicinal Chemistry at BeiGene Ltd.

Relationship likelihood: Strong

Jason Yang

Senior Vice President of Clinical Development & Operations at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Kang Li

Head of Biologics at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Lusong Luo

Head of Discovery Biology at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Zhiwei Wang

Research Head of Chemistry at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Min Wei

Head of Molecular Sciences at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
In The News
Business Wire
January 13, 2021
China National Medical Products Administration Approves Tislelizumab in Combination with Chemotherapy in First-Line Advanced Squamous Non-Small Cell Lung Cancer
ENP Newswire
April 13, 2020
-China National Medical Products Administration Approves BeiGene's Tislelizumab for Patients with Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma
Marketline Newswire
July 23, 2019
Beigene's Tislelizumab receives second priority review by China's NMPA
GlobeNewswire
November 15, 2018
Priority Review Granted to BeiGene's New Drug Applications for Zanubrutinib and Tislelizumab in China
ENP Newswire
September 3, 2018
-BeiGene Announces Acceptance of New Drug Application for Anti-PD-1 Antibody Tislelizumab in Hodgkin's Lymphoma in China
Trending People
Patrick Vallance
UK doctors seek review of 12-week gap between vaccine doses - Associated Press
Henry L. "Hank" Aaron
Home run king Aaron dies at 86THE QUOTE - South Florida Sun-Sentinel
Charles E. Schumer
February date set for Trump trialPelosi to send article of impeachment to Senate... - South Florida Sun-Sentinel
Jennifer Rene Psaki
Signing orders, urging more helpBiden offers some aid and asks Congress for bigg... - South Florida Sun-Sentinel
Boris Johnson
Rotting fish, lost business and piles of red tape. The reality of Brexit hits Br... - CNN
Trending People
Patrick Vallance
UK doctors seek review of 12-week gap between vaccine doses - Associated Press
Henry L. "Hank" Aaron
Home run king Aaron dies at 86THE QUOTE - South Florida Sun-Sentinel
Charles E. Schumer
February date set for Trump trialPelosi to send article of impeachment to Senate... - South Florida Sun-Sentinel
Jennifer Rene Psaki
Signing orders, urging more helpBiden offers some aid and asks Congress for bigg... - South Florida Sun-Sentinel
Boris Johnson
Rotting fish, lost business and piles of red tape. The reality of Brexit hits Br... - CNN
Paths to Wendy Yan
Potential Connections via
Relationship Science
You
Wendy Yan
Senior Vice President, Global Head of Regulatory Affairs at BeiGene Ltd.
Education
Staffordshire University

The University has a proud heritage of delivering inspiring, vocationally-led education for 100 years at the heart of a county that is renowned for its legacy of pioneering and creative industrialists. The University has evolved into the modern forward thinking organisation it is today, but stays true to its core values by ensuring it remains a constant source of creative, technological and scientific knowledge and skills for the future.

Beijing University of Traditional Chinese Medicine

Career History
Senior Vice President, Global Head of Regulatory Affairs
2014 - Current
BeiGene Ltd.

BeiGene Ltd. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. It focuses on Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317), and Pamiparib (BGB-290). The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Beijing, China.

Senior Vice President of Regulatory Affairs
2014 - Current
BeiGene (Beijing) Co., Ltd.

BeiGene (Beijing) Co., Ltd., part of BeiGene Ltd., is a company headquartered in Beijing, China, that develops pharmaceuticals.

Director & Head-Regulatory Affairs
Prior
GlaxoSmithkline Pharmaceuticals (Chongqing) Ltd.

GlaxoSmithkline Pharmaceuticals (Chongqing) Ltd., a subsidiary of Aurora Optoelectronics Co., Ltd., is a company headquartered in Chongqing, China. The firm manufactures pharmaceuticals and technical toxicants. Aurora Optoelectronics Co., Ltd. acquired GlaxoSmithkline Pharmaceuticals (Chongqing) Ltd. from GlaxoSmithKline Plc on 01 Feb 05 for $12.81 million.

Other Affiliations

Wendy Yan is affiliated with BeiGene Ltd., BeiGene (Beijing) Co., Ltd., GlaxoSmithkline Pharmaceuticals (Chongqing) Ltd., AstraZeneca LP

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Wendy Yan. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Wendy Yan's profile does not indicate a business or promotional relationship of any kind between RelSci and Wendy Yan.